High-Purity L-Carnitine Preparation via Chiral Intermediate Control
Solution Overview
Problem
Current methods for synthesizing high-purity L-carnitine lack effective control over chiral impurities, particularly D-carnitine, which can be harmful and reduce the optical purity of the final product, leading to potential health risks and increased production costs.
Innovation Solution
A method involving the detection and control of optical isomers in S-epichlorohydrin, L-3-chloro-2-hydroxypropyl trimethylamine, and L-3-cyan-2-hydroxypropyl trimethylamine using GC, polarimetry, and chiral derivatization reagents to maintain purity above 97% and D-carnitine content below 2%, ensuring high optical purity and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis is used to produce L-carnitine, then production cost is reduced and scalability is improved, but D-carnitine impurity is generated reducing optical purity and causing health risks
Solution Approach 1:
The patent applies preliminary action by detecting and controlling the optical purity of chiral intermediates (S-epichlorohydrin, L-3-chloro-2-hydroxypropyl trimethylamine, L-3-cyan-2-hydroxypropyl trimethylamine) at each synthesis step before proceeding to the next step. This prevents D-carnitine impurity from accumulating in the final product while maintaining efficient chemical synthesis pathways.
Solution Approach 2:
The patent implements feedback control by establishing detection mechanisms that monitor the optical purity of intermediates and adjust the synthesis process accordingly. The detection results are used to control the content of chiral materials and intermediates, ensuring D-carnitine content remains below 2% while maintaining high L-carnitine purity above 97%.
2Reliability
If chiral separation is performed to remove D-carnitine, then optical purity is improved, but production cost increases and process complexity increases
Solution Approach 1:
Instead of performing complex chiral separation after synthesis, the patent applies preliminary action by controlling the optical purity of chiral intermediates at each synthesis step. This prevents D-carnitine formation at the source, eliminating the need for complex separation processes while maintaining high optical purity.
Solution Approach 2:
The patent extracts the harmful D-carnitine impurity problem by focusing on controlling the chiral intermediates that lead to its formation. By detecting and controlling the optical purity of intermediates like S-epichlorohydrin and the quaternary ammonium salt, the method removes the root cause of D-carnitine contamination without needing complex separation technologies.
3Manufacturing precision
If detection of optical isomers is performed at each step, then control precision is improved, but measurement cost and time increase
Solution Approach 1:
The patent applies preliminary action by performing optical isomer detection at each synthesis step before the next step begins. This ensures that intermediates meet the required optical purity specifications (S-epichlorohydrin: 88-97%, L-3-chloro-2-hydroxypropyl trimethylamine: 90-98%, L-3-cyan-2-hydroxypropyl trimethylamine: 92-99%) and prevents time-consuming rework or rejection of batches later in the process.
Solution Approach 2:
The patent implements feedback control by using detection results to adjust the synthesis process in real-time. The detection of optical isomers in intermediates provides feedback that allows for process optimization, ensuring consistent high purity product while minimizing detection time through efficient methodology.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach ensures high-purity L-carnitine production by accurately monitoring and controlling chiral intermediates, reducing the risk of D-carnitine impurities, lowering production costs, and minimizing environmental impact.
Implementation Method 1
Detect the content of optical isomers of S-epichlorohydrin with GC and chiral column
Implementation Method 2
Detect the specific rotation of the intermediate L-3-chloro-2-hydroxypropyl trimethylamine during the synthetic process with a polarimeter
Implementation Method 3
Detect the optical purity of L-3-cyan-2-hydroxypropyl trimethylamine of the intermediate mixture and the content of its dextroisomer with a chiral derivatization reagent
Data Source
AI summary
The present invention relate to a preparation method of high-purity L-carnitine which belongs to an important technique of quality control in different steps of chiral medicine production. The method comprises the following steps of: monitoring the content of the L-isomer impurity in chiral material S-epichlorohydrin by gas chromatography and chiral column and controlling the content of the L-isomer impurity in chiral raw material in the definite range; monitoring and controlling the specific optical rotation of the chiral intermediate L-3-chloro-2-hydroxy-N,N,N-trimethyl-propanaminium in the definite ranges using a polarimeter; monitoring the content of the R-isomer in the intermediate L-3-cyano-2-hydroxy-N,N,N-trimethyl-propanaminium using derivation agent (+)α-methyl-6-methoxy-2-naphthaleneaceyl chloride by HPLC and controlling the content of the isomer in the intermediate in the definite range; and measuring the final product L-carnitine using derivation agent (+)α-methyl-6-methoxy-2-naphthaleneaceyl chloride by HPLC. This method gives the high-purity L-carnitine in which the content of L-isomer may be more than 97% and that of R-isomer less than 2%.